Hutchison M - Search Results

1

Drusano GL, Hutchison M. Drusano GL, et al. Among authors: hutchison m. Scand J Infect Dis Suppl. 1995;96:11-6. Scand J Infect Dis Suppl. 1995. PMID: 7652497 Review.

2

Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.

Nilsson-Ehle I, Hutchison M, Haworth SJ, Norrby SR. Nilsson-Ehle I, et al. Among authors: hutchison m. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):85-8. doi: 10.1007/BF01964413. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864280 Clinical Trial.

3

Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.

Christensson BA, Nilsson-Ehle I, Hutchison M, Haworth SJ, Oqvist B, Norrby SR. Christensson BA, et al. Among authors: hutchison m. Antimicrob Agents Chemother. 1992 Jul;36(7):1532-7. doi: 10.1128/AAC.36.7.1532. Antimicrob Agents Chemother. 1992. PMID: 1510451 Free PMC article.

4

A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Jones HK, Kelly HC, Hutchison M, Yates RA, Ross F, Lomax C, Freestone S, Webb D. Jones HK, et al. Among authors: hutchison m. Eur J Drug Metab Pharmacokinet. 1997 Jul-Sep;22(3):193-9. doi: 10.1007/BF03189806. Eur J Drug Metab Pharmacokinet. 1997. PMID: 9358198

5

The pharmacokinetics of meropenem in volunteers.

Bax RP, Bastain W, Featherstone A, Wilkinson DM, Hutchison M, Haworth SJ. Bax RP, et al. Among authors: hutchison m. J Antimicrob Chemother. 1989 Sep;24 Suppl A:311-20. doi: 10.1093/jac/24.suppl_a.311. J Antimicrob Chemother. 1989. PMID: 2808215 Clinical Trial.

6

Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.

Burman LA, Nilsson-Ehle I, Hutchison M, Haworth SJ, Norrby SR. Burman LA, et al. Among authors: hutchison m. J Antimicrob Chemother. 1991 Feb;27(2):219-24. doi: 10.1093/jac/27.2.219. J Antimicrob Chemother. 1991. PMID: 2055812

7

A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.

Kelly HC, Hutchison M, Haworth SJ. Kelly HC, et al. Among authors: hutchison m. J Antimicrob Chemother. 1995 Jul;36 Suppl A:35-41. doi: 10.1093/jac/36.suppl_a.35. J Antimicrob Chemother. 1995. PMID: 8543497

8

The pharmacokinetics of meropenem in infants and children: a population analysis.

Parker EM, Hutchison M, Blumer JL. Parker EM, et al. Among authors: hutchison m. J Antimicrob Chemother. 1995 Jul;36 Suppl A:63-71. doi: 10.1093/jac/36.suppl_a.63. J Antimicrob Chemother. 1995. PMID: 8543500

9

Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration.

Krueger WA, Schroeder TH, Hutchison M, Hoffmann E, Dieterich HJ, Heininger A, Erley C, Wehrle A, Unertl K. Krueger WA, et al. Among authors: hutchison m. Antimicrob Agents Chemother. 1998 Sep;42(9):2421-4. doi: 10.1128/AAC.42.9.2421. Antimicrob Agents Chemother. 1998. PMID: 9736574 Free PMC article.

10

A compilation of meropenem tissue distribution data.

Hutchison M, Faulkner KL, Turner PJ, Haworth SJ, Sheikh W, Nadler H, Pitkin DH. Hutchison M, et al. J Antimicrob Chemother. 1995 Jul;36 Suppl A:43-56. doi: 10.1093/jac/36.suppl_a.43. J Antimicrob Chemother. 1995. PMID: 8543498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page